Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eton Pharmaceuticals (ETON) Non Operating Income (2019 - 2024)

Historic Non Operating Income for Eton Pharmaceuticals (ETON) over the last 6 years, with Q4 2024 value amounting to -$1.1 million.

  • Eton Pharmaceuticals' Non Operating Income fell 702500.0% to -$1.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$1.2 million, marking a year-over-year decrease of 34075.55%. This contributed to the annual value of -$1.2 million for FY2024, which is 34075.55% down from last year.
  • As of Q4 2024, Eton Pharmaceuticals' Non Operating Income stood at -$1.1 million, which was down 702500.0% from -$8000.0 recorded in Q3 2024.
  • Eton Pharmaceuticals' 5-year Non Operating Income high stood at $676000.0 for Q2 2023, and its period low was -$1.1 million during Q4 2024.
  • Over the past 5 years, Eton Pharmaceuticals' median Non Operating Income value was -$171000.0 (recorded in 2020), while the average stood at -$149900.0.
  • In the last 5 years, Eton Pharmaceuticals' Non Operating Income soared by 41009.17% in 2023 and then plummeted by 702500.0% in 2024.
  • Eton Pharmaceuticals' Non Operating Income (Quarter) stood at -$267000.0 in 2020, then fell by 3.0% to -$275000.0 in 2021, then soared by 45.45% to -$150000.0 in 2022, then skyrocketed by 89.33% to -$16000.0 in 2023, then tumbled by 7025.0% to -$1.1 million in 2024.
  • Its last three reported values are -$1.1 million in Q4 2024, -$8000.0 for Q3 2024, and -$52000.0 during Q2 2024.